HU9402816D0 - Medicament for the treatment of airways inflammation and airways hyperresponsiveness - Google Patents

Medicament for the treatment of airways inflammation and airways hyperresponsiveness

Info

Publication number
HU9402816D0
HU9402816D0 HU9402816A HU9402816A HU9402816D0 HU 9402816 D0 HU9402816 D0 HU 9402816D0 HU 9402816 A HU9402816 A HU 9402816A HU 9402816 A HU9402816 A HU 9402816A HU 9402816 D0 HU9402816 D0 HU 9402816D0
Authority
HU
Hungary
Prior art keywords
airways
medicament
treatment
hyperresponsiveness
inflammation
Prior art date
Application number
HU9402816A
Other languages
English (en)
Other versions
HUT75702A (en
Inventor
Barbara Anne Spicer
Stephen Gerard Taylor
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HU9402816D0 publication Critical patent/HU9402816D0/hu
Publication of HUT75702A publication Critical patent/HUT75702A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9402816A 1992-04-02 1993-03-26 Medicament for the treatment of airways inflammation and airways hyperresponsiveness HUT75702A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929207400A GB9207400D0 (en) 1992-04-02 1992-04-02 Novel use

Publications (2)

Publication Number Publication Date
HU9402816D0 true HU9402816D0 (en) 1994-12-28
HUT75702A HUT75702A (en) 1997-05-28

Family

ID=10713459

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402816A HUT75702A (en) 1992-04-02 1993-03-26 Medicament for the treatment of airways inflammation and airways hyperresponsiveness

Country Status (11)

Country Link
EP (1) EP0633778A1 (hu)
JP (1) JPH07505381A (hu)
KR (1) KR950700737A (hu)
AU (1) AU3765193A (hu)
CA (1) CA2133470A1 (hu)
GB (1) GB9207400D0 (hu)
HU (1) HUT75702A (hu)
IL (1) IL105233A0 (hu)
MX (1) MX9301879A (hu)
WO (1) WO1993019755A1 (hu)
ZA (1) ZA932303B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
WO2004052863A1 (ja) * 2002-12-06 2004-06-24 Kyowa Hakko Kogyo Co., Ltd. 抗炎症剤
CA2541014A1 (en) 2003-10-01 2005-04-14 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
WO2015157262A1 (en) 2014-04-07 2015-10-15 Women & Infants Hospital Of Rhode Island Novel 7-Dehydrocholesterol Derivatives and Methods Using Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI90343C (fi) * 1987-06-23 1994-01-25 Merck Patent Gmbh Menetelmä korkeaa verenpainetta alentavien ja rytmihäiriöitä vastustavien trans-2,2-dimetyylikroman-3-olijohdannaisten valmistamiseksi
IL88035A0 (en) * 1987-10-27 1989-06-30 American Home Prod Benzopyran derivatives,their preparation and pharmaceutical compositions containing them
ATE120459T1 (de) * 1988-12-13 1995-04-15 Beecham Group Plc Benzopyran und verwandte verbindungen.
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators

Also Published As

Publication number Publication date
AU3765193A (en) 1993-11-08
GB9207400D0 (en) 1992-05-13
EP0633778A1 (en) 1995-01-18
HUT75702A (en) 1997-05-28
JPH07505381A (ja) 1995-06-15
WO1993019755A1 (en) 1993-10-14
KR950700737A (ko) 1995-02-20
MX9301879A (es) 1993-12-01
CA2133470A1 (en) 1993-10-14
ZA932303B (en) 1994-06-06
IL105233A0 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
AU2806692A (en) Medicament for the treatment of anxiety
IL115320A0 (en) Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
ZA932303B (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
AU4220193A (en) Deazaaminopterins for treatment of inflammation
GB9103278D0 (en) Drug for the treatment of dermatitis
ZA932450B (en) Drugs for the treatment of diabetes
AU4081393A (en) Medicaments for the treatment of anxiety
PL307050A1 (en) Therapeutic system and method of obtaining same
ZA938897B (en) Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds
AU4119993A (en) Heteroaroyl-10-deazaaminopterins for treatment of inflammation
EP0502470A3 (en) Compounds for the treatment of inflammation and allergy
GB2220652B (en) Treatment of pastures
GB2266241B (en) Treatment of pastures
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
ZA931700B (en) Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients
ZA936136B (en) Treatment of skin diseases
GB9207595D0 (en) Treatment of pastures
GB9216360D0 (en) Treatment of blood
BG98001U (en) Medicament for the treatment of hyperkeratotic conditions of the skin
PH27501A (en) Pharmaceutical formulation and method for the treatment of diabetes mellitus
GB2270260B (en) Lactide copolymers for topical treatment of the skin
AU3286893A (en) Therapeutic device and method of treatment

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee